Post-approval studies (Phase 4)Study completedNCT04447911
What this trial is testing
Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia
Who this might be right for
HyponatremiaSIADHLiver Failure+1 more
University Hospital, Basel, Switzerland 113